Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
MONTKUSH CBD Review
Their lab report is honest and their compliance claim is true. The law it relies on has 96 days left.
MONTKUSH CBD
96 Days To A Legal CliffCredit first, because we checked and expected worse: Landrace Bioscience measured the Cherry Limeade gummy at 5.529mg delta-9 THC and 27.540mg CBD against a 5mg and 25mg label — accurate, slightly over-delivering. THCA, delta-8, delta-10, HHC, THCO and THCP all not detected. At 0.112% by weight, their "2018 Farm Bill Compliant" claim is simply true.
But the test changes on 12 November 2026: Section 781 of the 2026 appropriations law caps finished consumable hemp products at 0.4mg total THC per innermost retail container. One 5.529mg gummy is already about 13.8 times a whole container's future allowance. The 60-count jar at $89.99 holds roughly 331.7mg — about 829 times.
And the flagship COA expired 19 months ago: the certificate linked from the delta-9 page covers lot 01102024, received 10 January 2024, and prints its own expiry as “Expires: 01/10/2025”. Their library holds 32 certificates including current 2026 batches for other products, so the practice is real — this document is just stale.
To be fair: this is not an accusation of wrongdoing. Everything here is lawful today and we verified that against their own lab report. It is a warning about a purchase with a date on it — so buy the $9.99 three-pack rather than the $89.99 jar, or take the THC-free broad-spectrum line, which the change does not touch.
Affiliate disclosure: This programme pays GLP1Drugs.org a flat $30 per sale — the largest payout in this batch, and far above the 3 to 6% we usually earn. We are paid the same $30 on a $9.99 three-pack as on a $109.99 jar, which is exactly why we are telling you to buy the small one. Verified 8 August 2026.
Visit MONTKUSHOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
96
Days Until The Rule Changes
0.4mg
New Cap, Total THC Per Container
5.529mg
Measured THC In One Gummy
829×
The 60-Count Jar Versus The Cap
What We Verified
We downloaded and read the actual certificate of analysis rather than trusting the badge, and did the per-container arithmetic ourselves from the measured figure.
The Lab Report Backs The Label, Which Is Not Always True
Landrace Bioscience of Chattanooga, Tennessee measured the Cherry Limeade gummy at 5.529mg delta-9 THC and 27.540mg CBD per gummy, against a label of 5mg THC and 25mg CBD. Slightly over-delivering on both. THCA and every other THC isomer came back ND — no delta-8, no THCO, no HHC, no loophole games
And It Is Genuinely Farm Bill Compliant Today
The same COA puts delta-9 THC at 0.112% by weight, comfortably inside the 2018 Farm Bill's 0.3% dry-weight ceiling. When MONTKUSH says "2018 Farm Bill Compliant", that is a true statement about the law as it stands. We checked rather than assumed
But The Test Itself Changes On 12 November 2026
Section 781 of the 2026 appropriations law redefines hemp to a total-THC basis inclusive of THCA and delta-8, and caps finished consumable hemp products at 0.4mg total THC per container — "container" meaning the innermost vessel sold at retail. That is 96 days from this review
A Single Gummy Is Already 13.8 Times The New Limit
At the measured 5.529mg, one gummy exceeds a whole container's future allowance by nearly fourteen times. The 20-count jar at $39.99 holds about 110.6mg, roughly 276 times the cap. The 60-count at $89.99 holds about 331.7mg — about 829 times
The Sleep Products Are Over It Too
The 1mg-THC full-spectrum line does not escape. A 30-count jar of True Sleep gummies carries about 30mg total THC and the 60-count about 60mg, roughly 75 and 150 times the coming per-container cap. Same for the full-spectrum softgels at 1mg apiece
The Flagship Product's COA Expired 19 Months Ago
The certificate linked from the delta-9 gummy page is for lot 01102024, received 10 January 2024, and states on its face "Expires: 01/10/2025". Their COA library holds 32 certificates including 2026 batches for other products, so the practice is real — this particular document is just long out of date
Every THC Product Against The New Cap
Delta-9 figures use the measured 5.529mg per gummy from their own COA. Sleep products use the labelled 1mg. Our arithmetic, from their numbers.
| Container | Price | Total THC | vs 0.4mg Cap |
|---|---|---|---|
| Delta-9 gummies, 3-count | $9.99 | ~16.6 mg | ~41× — the least bad option |
| Delta-9 gummies, 20-count | $39.99 | ~110.6 mg | ~276× |
| Delta-9 gummies, 60-count | $89.99 | ~331.7 mg | ~829× |
| True Sleep gummies, 60-count | $109.99 | ~60 mg | ~150× |
| Full-spectrum softgels, 60-count | $99.99 | ~60 mg | ~150× |
| Broad-spectrum, THC-free line | $59.99–$64.99 | Non-detectable | Unaffected — buy this instead |
Topicals are a genuine grey area — the cap covers products intended for human consumption, and creams are not consumed — so we are not going to assert how they land. State law is a separate and messier question we have deliberately not attempted; check your own state rather than trusting any list, including one we might write.
Why Edibles Are Riskier On These Medicines
General guidance, not medical advice, and we earn nothing on any of it.
| The Interaction | What It Means In Practice |
|---|---|
| Delayed gastric emptying | Onset is later and less predictable — the classic setup for taking a second one too soon |
| THC increases appetite | Pharmacologically working against the medication you are paying for |
| Two causes of the same vomiting | Cannabis hyperemesis and GLP-1 nausea look alike — tell your clinician about the cannabis |
| CBD inhibits CYP3A4 and CYP2C19 | Not a GLP-1 problem — but a real one for many other drugs. Ask a pharmacist, it is free |
If you use edibles at all: take one, then wait at least four hours before considering another, regardless of what your previous experience suggests. Our side-effects guide covers the nausea and gastric-emptying side in more detail.
Pros & Cons
Pros
- ✓A genuine, organised COA library at coa.montkush.com — 32 certificates sorted by gummies, oils, softgels and topicals
- ✓Several products carry current certificates, including 2026 batches for the True Sleep softgels and variety gummies
- ✓The delta-9 gummy COA corroborates the label rather than contradicting it, at 5.529mg THC and 27.540mg CBD measured
- ✓THCA, delta-8, delta-10, THCO, HHC and THCP all came back not detected — no synthetic-isomer or THCA loophole products
- ✓Full cannabinoid panel from a named third-party laboratory with an address and contact details on the certificate
- ✓A real Vermont farm story with USDA Organic certification claimed on at least one product line
- ✓A broad-spectrum, THC-free line exists and is described as "THC-Free (Non-Detectable on COA)"
- ✓Per-container and per-serving milligram figures are stated plainly on product listings, which makes this arithmetic possible at all
- ✓We found no FDA warning letter to MONTKUSH in the searches we ran
Cons
- ✕Much of the THC-containing catalogue becomes non-compliant with the federal hemp definition on 12 November 2026
- ✕A 60-count delta-9 jar at $89.99 holds roughly 829 times the coming 0.4mg per-container limit
- ✕Nothing on the site we saw warns buyers that the legal basis it cites is 96 days from changing
- ✕The marketing line "All products comply with the 2018 Farm Bill and contain less than 0.3% Delta-9 THC by dry weight" will be the wrong test after that date
- ✕The delta-9 gummy's linked certificate is for a January 2024 lot and states its own expiry as 01/10/2025
- ✕Two other product pages we checked linked only the COA homepage, not a lot-specific certificate
- ✕THC raises appetite, which works directly against a medication prescribed to suppress it
- ✕Delayed gastric emptying makes edible onset slower and less predictable — the classic setup for accidental redosing
- ✕FDA has not approved CBD as a dietary supplement or food ingredient, whatever the marketing implies
- ✕We paid the most attention here because the payout is the largest in this batch: $30 flat per sale
Our Verdict
2.9 / 5 — a credible producer selling a lot of product with 96 days on the clock.
We should start with the part that surprised us, because we approached this expecting the usual. Hemp companies advertise third-party testing constantly and the documents behind the claim are frequently missing, stale, or quietly testing for the wrong things. MONTKUSH has a genuine certificate library at coa.montkush.com — 32 documents sorted into gummies, oils, softgel caps, strength and topicals, several of them current 2026 batches. We downloaded the certificate for the Cherry Limeade delta-9 gummy and read it in full. It comes from Landrace Bioscience of Chattanooga, Tennessee, sample 01-10-2024-44196, and it is a proper analytical document with limits of detection and quantitation, a stated measurement of uncertainty, and a panel of more than twenty cannabinoids. It measured 5.529mg of delta-9 THC and 27.540mg of CBD per gummy against a label of 5mg and 25mg — accurate, slightly over-delivering, which is the right direction to be wrong in. THCA, delta-8, delta-10, THCP, THCV, HHC and THCO were all not detected, meaning this is farm-grown full-spectrum material rather than the converted-isomer chemistry behind hemp's worst headlines. And at 0.112% delta-9 by weight, the claim that these products comply with the 2018 Farm Bill is simply, verifiably true.
So the problem is not honesty. The problem is the calendar. Section 781 of the appropriations law for 2026 redefines hemp on a total-THC basis inclusive of THCA and delta-8, and caps finished hemp-derived products intended for human consumption at 0.4 milligrams of total THC per container — where container means the innermost wrapping, packaging or vessel sold at retail. That takes effect on 12 November 2026, which is 96 days from this review. The U.S. Hemp Roundtable has estimated that around 95% of existing hemp-derived cannabinoid products would fall outside the new definition. Run MONTKUSH's own measured number against it and the scale is hard to overstate. A single gummy at 5.529mg is roughly 13.8 times what an entire container will be permitted to hold. The 3-count pack at $9.99 comes to about 16.6mg, some 41 times the cap. The 20-count jar at $39.99 is about 110.6mg, roughly 276 times. The 60-count jar at $89.99 is about 331.7mg — approximately 829 times the limit. And this is not confined to the obviously intoxicating line: the gentle 1mg-THC full-spectrum sleep products land at roughly 30mg per 30-count jar and 60mg per 60-count, which is 75 to 150 times over.
We want to be careful about what that does and does not mean, because it would be easy to write this as an accusation and it is not one. Everything MONTKUSH is selling is lawful today under the standard they cite, and we verified that against their own laboratory data rather than taking it on trust. They are not evading the current rule; they are complying with it. The criticism is narrower and it is about disclosure: nothing we saw on the site tells a customer that the legal basis it repeatedly invokes has a known expiry date three months out, and the products most affected are precisely the large-format ones the pricing encourages you to buy. A 60-count jar is roughly a two-month supply for a nightly user, which means someone buying it today may still be holding it when the definition changes. That is a material fact about the purchase, and the customer is the person who ought to be told. Two smaller criticisms belong here too. The certificate linked from the flagship delta-9 product covers lot 01102024, was received on 10 January 2024, and prints its own expiry as 01/10/2025 — more than nineteen months before we read it, while other products in the same library show 2026 batches. And two other product pages we checked linked only to the library homepage rather than to the certificate for that product, which leaves you to find the right document yourself.
On the medical side there is one point we think is genuinely under-discussed and matters more than the legal one for anybody's actual safety. These medicines slow gastric emptying deliberately, and gastric emptying is the first step in absorbing an edible. Onset, normally somewhere between half an hour and two hours, can therefore be later and considerably less predictable — and the failure mode is entirely foreseeable: nothing happens, so you take a second one, and then both land together. That is a well-worn route to several unpleasant hours of anxiety, tachycardia and vomiting. If you use edibles, take one and wait at least four hours before even considering another, whatever your prior experience tells you. Two further points. THC reliably stimulates appetite, so taking it alongside a medicine prescribed to suppress appetite is working against yourself, and that is worth weighing honestly rather than ignoring. And cannabis hyperemesis syndrome produces cyclical vomiting in regular users while nausea and vomiting are also among the commonest effects of these drugs — so if you use THC regularly and are vomiting persistently, say so to your clinician, because two candidate explanations for one symptom is exactly how diagnoses get delayed. Separately, CBD inhibits CYP3A4 and CYP2C19, which is not a GLP-1 concern since those are peptides cleared by proteolysis, but is very much a concern if you take other regular medication. Ask a pharmacist; it costs nothing.
So what should you actually do. If you want CBD or CBN without a countdown attached, buy the broad-spectrum line — the True Daily broad-spectrum softgels at $59.99 or the True Sleep Advanced Formula at $64.99, the latter described as THC-Free and non-detectable on its COA. A product with no detectable THC is untouched by a per-container THC cap. If you want to try the THC products, buy the $9.99 three-pack rather than the $89.99 jar, and check the certificate for the lot you are actually sent rather than the one linked on the page. Do not stock up. We have not attempted the state-law question, which is separate, contradictory and changes constantly — check your own state rather than trusting any list, and that includes one we might have written. And weigh our disclosure heavily on this one: MONTKUSH pays a flat $30 per sale, the biggest payout of anything we have reviewed lately and several times what our usual percentage deals return. We earn exactly the same $30 whether you spend $9.99 or $109.99, which is the only reason you should believe us when we tell you to buy the small one.
Visit MONTKUSHFrequently Asked Questions
What is happening on 12 November 2026?
The federal definition of hemp changes, and with it the test that makes most of these products legal. Under the 2018 Farm Bill, hemp has been defined by delta-9 THC concentration: not more than 0.3% on a dry weight basis. That is a concentration test, and it is why a large gummy can legally contain several milligrams of THC — the THC is a small fraction of the weight of the sweet. Section 781 of the appropriations law for 2026 changes two things. First, hemp is redefined on a total-THC basis, inclusive of THCA and delta-8, closing the loophole that allowed products high in non-delta-9 cannabinoids to qualify. Second, and decisively for edibles, finished hemp-derived cannabinoid products intended for human consumption are capped at 0.4 milligrams of total THC per container, where container means the innermost wrapping, packaging or vessel in which the product is sold at retail. The provisions take effect on 12 November 2026, which is 96 days from the date of this review. The U.S. Hemp Roundtable has estimated that roughly 95% of existing hemp-derived cannabinoid products would be federally unlawful under that standard. To be scrupulously fair to MONTKUSH: nothing they are doing is unlawful today, their compliance claim is accurate as of now, and we verified it against their own lab report. This is not an accusation. It is a warning about a purchase with a date on it, and the larger the jar, the more it matters.
How far over the new limit are these products?
Very far, and we can be precise because their own certificate of analysis gives us a measured number rather than a label claim. The Cherry Limeade delta-9 gummy was tested by Landrace Bioscience of Chattanooga, Tennessee, sample 01-10-2024-44196, and measured 5.529mg of delta-9 THC per gummy, with every other THC isomer — THCA, delta-8, delta-10, THCO, HHC, THCP, THCV — reported as not detected. So total THC is essentially the delta-9 figure. Now do the arithmetic against a 0.4mg per-container cap. One gummy, on its own, is about 13.8 times a whole container's future allowance. The 3-count pack at $9.99 holds roughly 16.6mg, about 41 times. The 20-count jar at $39.99 holds about 110.6mg, roughly 276 times. The 40-count at $69.99, about 221mg or 553 times. The 60-count at $89.99, about 331.7mg — roughly 829 times the coming limit. And it is not only the obviously intoxicating line. The full-spectrum sleep range carries 1mg of THC per unit: a 30-count jar of True Sleep gummies is about 30mg total THC and the 60-count about 60mg, or roughly 75 and 150 times the cap. The full-spectrum softgels at 1mg each are the same. The broad-spectrum and THC-free products are a different story and are discussed below. The practical implication is simple: if you want to try these, buy the smallest size, not the value jar, because the value jar is the one you will still be holding in November.
Is their lab testing any good?
Yes, mostly, and we went in expecting worse. There is a dedicated certificate library at coa.montkush.com holding 32 certificates organised into gummies, oils, softgel caps, strength and topicals, and several are current — the True Sleep softgels show a 2026 batch, as does a variety gummy lot. The certificate we read in full is a proper document: a named laboratory with a street address and contact details, a full cannabinoid panel covering twenty-odd analytes with limits of detection and quantitation stated, and a measurement of uncertainty. Most importantly, it corroborates the label instead of quietly contradicting it. The gummy is sold as 25mg CBD and 5mg THC; the lab measured 27.540mg CBD and 5.529mg delta-9 THC per gummy. Slightly over on both, which is normal and unremarkable. That matters because label accuracy in this industry is genuinely patchy, and a company whose numbers survive contact with its own lab report deserves the credit. The panel also shows no delta-8, no THCO, no HHC and no THCA, which means these are not the synthetic-isomer or THCA-flower products that have given hemp its worst headlines. Two criticisms. The certificate linked from the delta-9 product page is for lot 01102024, received on 10 January 2024, and carries a printed expiry of 01/10/2025 — so the document the flagship product points at expired more than nineteen months before we read it. And two other product pages we checked linked only to the library homepage rather than to a lot-specific certificate, which puts the work of finding the right document back on you.
Why does a GLP-1 site care about edibles specifically?
Because these medicines slow gastric emptying, and that is precisely the mechanism that makes an edible unpredictable. This is the most useful thing on this page and we have not seen it said clearly anywhere else. An edible has to pass through the stomach, be absorbed in the small intestine and be metabolised by the liver before you feel anything — which is why onset is normally somewhere between half an hour and two hours, and why people who are used to inhaling misjudge them. GLP-1 receptor agonists deliberately slow the first step in that chain. The consequence is that onset can be later and more variable than you expect, and the failure mode is well known and entirely predictable: nothing seems to be happening, so you take another one, and then both arrive at once. That is the classic route to an unpleasant few hours of anxiety, a racing heart and vomiting, and it is a common reason people end up in urgent care after edibles. So if you use them at all: take one, and then do not take another for at least four hours, no matter what your previous experience tells you. There is a second point worth making plainly. THC reliably increases appetite. Taking it while paying for a medicine whose entire purpose is to suppress appetite is working against yourself pharmacologically, and it is a reasonable thing to weigh. And a third, which is a genuine clinical trap: cannabis hyperemesis syndrome causes cyclical vomiting in regular users, and nausea and vomiting are also among the most common side effects of these medicines. If you use THC regularly and are vomiting persistently, tell your clinician about the cannabis use, because two plausible causes of the same symptom is exactly how a diagnosis gets delayed.
Which of their products are unaffected?
The THC-free line, and that is what we would actually point you at. MONTKUSH sells products on both sides of the coming line, which makes this easier than it might be. Their broad-spectrum range is described as THC-free — the True Sleep Advanced Formula softgels are listed explicitly as "THC-Free (Non-Detectable on COA)" — and a product with no detectable THC is not troubled by a 0.4mg per-container cap. That range includes the True Daily broad-spectrum 50mg CBD softgels at $59.99 and the True Sleep Advanced Formula CBN and CBD softgels at $64.99. If you want CBD or CBN without the legal expiry date, those are the coherent choices. Two things we cannot resolve for you. The CBDA rosin gummies are full-spectrum and marketed on CBDA rather than THC content, and without a per-container THC figure from a current certificate we cannot tell you where they land — check the certificate for the lot you are sent. And topicals are genuinely unclear: the 0.4mg cap applies to products intended for human consumption, and creams, salves and roll-ons are not consumed, so their treatment under the new definition is not something we are going to assert either way. If that distinction matters to your purchase, take advice rather than taking our word. The general rule for the next three months is straightforward: if the product contains THC and you are buying more than a few servings, you are buying something with a shorter legal life than its shelf life.
Does CBD interact with GLP-1 medications?
Not in the way people usually worry about, but there are two real considerations. CBD is a known inhibitor of several cytochrome P450 liver enzymes, notably CYP3A4 and CYP2C19, which is why it can raise levels of a long list of other drugs — that is a genuine and well-documented interaction risk. GLP-1 receptor agonists, however, are peptides broken down by general proteolytic degradation rather than cleared through those enzyme pathways, so a direct CYP-mediated interaction with the GLP-1 itself is not the concern. The concern runs the other way and applies to everything you swallow: by slowing gastric emptying, these medicines can change the rate and predictability with which oral medications and supplements are absorbed. That is worth mentioning to a pharmacist if you take anything where timing or blood levels matter, and it is the reason the edible-onset problem above is not a theoretical one. The second consideration is that if you take other regular medication — blood thinners, anti-epileptics, certain statins, immunosuppressants and many others — CBD's enzyme inhibition can matter a great deal, entirely independently of your GLP-1. That is a pharmacist conversation, and pharmacists are free. One last thing worth stating because the marketing tends to blur it: the FDA has not approved CBD as a dietary supplement or as a food ingredient, and no CBD product discussed here is approved to treat, prevent or cure anything. Claims about sleep, pain or anxiety on any hemp website, including this one's subject, are marketing rather than regulatory findings.
Should I buy from them before the deadline?
If you want these products, buy small and buy soon, or buy the THC-free line and ignore the deadline entirely. Here is the honest calculus. The company appears to be a real Vermont farm rather than a white-label operation, its lab report survived our scrutiny, its labels are accurate, and the panel is free of the synthetic isomers that characterise the worst of this industry. We found no FDA warning letter in the searches we ran. So this is not a warning about the seller. It is a warning about timing. Products priced for stocking up — the 60-count delta-9 jar at $89.99, the 60-count sleep gummies at $109.99 — are exactly the products you should not stock up on, because on 12 November 2026 you will be holding a supply whose federal legal basis has changed underneath it. Buying the 3-count at $9.99 to find out whether you like something is sensible; buying three months of it is not. Also worth knowing: state law is a separate and messier question that we have deliberately not attempted here, because the state-by-state picture for hemp THC is contradictory and changes constantly, and we would rather tell you to check your own state than publish a list we cannot stand behind. And our own position should shape how you read all of this. This programme pays us a flat $30 per sale — the largest payout of anything we have reviewed recently, and far more than the 3 to 6 per cent we typically earn. A $9.99 three-pack earns us the same $30 as a $109.99 jar, which is precisely why we have spent this review telling you to buy the small one.
What is your verdict?
2.9 out of 5 — a credible producer selling a lot of product with 96 days on the clock. Let us separate the two things this rating combines, because they point in opposite directions. On execution, MONTKUSH does better than most of the hemp companies we have looked at. There is a real certificate library at coa.montkush.com with 32 documents sorted by category, several of them current 2026 batches. The certificate we read in full, from Landrace Bioscience in Chattanooga, is a proper analytical document with limits of detection, measurement uncertainty and a twenty-plus analyte panel — and crucially it confirms the label rather than undermining it, at 5.529mg delta-9 THC and 27.540mg CBD against a stated 5mg and 25mg. THCA, delta-8, delta-10, HHC, THCO and THCP were all not detected, meaning this is straightforwardly farm-grown full-spectrum material rather than converted-isomer chemistry. At 0.112% delta-9 by weight, their claim of 2018 Farm Bill compliance is simply true. We looked for a reason to distrust the numbers and did not find one. On timing, the picture is entirely different. Section 781 of the 2026 appropriations law redefines hemp on a total-THC basis and caps finished consumable products at 0.4mg total THC per container from 12 November 2026 — 96 days away. Measured against that, one gummy is already about 13.8 times a full container's allowance; the 20-count jar is roughly 276 times; the 60-count jar at $89.99 is roughly 829 times. Even the gentle 1mg-THC sleep line lands at 75 to 150 times the cap per jar. Nothing on the site we saw mentions this, and the marketing still recites the 0.3% dry-weight test that is about to stop being the test. Add a flagship product whose linked certificate expired in January 2025, and the buying advice writes itself: take the THC-free broad-spectrum line if you want something durable, or buy the smallest THC pack rather than the value jar, and check the certificate for the lot you actually receive. Our disclosure, which matters more here than usual: we are paid a flat $30 whether you spend $9.99 or $109.99, and we have spent this review recommending the $9.99 option.
Buy The Small One. Or The THC-Free One.
The $89.99 jar holds roughly 829 times the cap that arrives on 12 November 2026. The broad-spectrum line is non-detectable and untouched. We are paid the same $30 either way.
Visit MONTKUSHCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Henry Meds
Top RatedWell-established telehealth platform with fast physician reviews and competitive pricing
Read Review →LifeMD
Top RatedPublicly traded telehealth company with comprehensive health platform and competitive pricing
Read Review →Alan Meds
Top RatedAffordable compounded GLP-1s with board-certified physicians and straightforward pricing
Read Review →BeyondMD
Top RatedBoard-certified physician-led care with comprehensive medical oversight
Read Review →Mochi Health
Obesity Medicine SpecialistsBoard-certified obesity medicine specialists with both brand-name and compounded GLP-1 options
Read Review →PlushCare
Insurance AcceptedMajor telehealth platform with brand-name FDA-approved GLP-1s, insurance support, and 1M+ members treated
Read Review →Medical Disclaimer: This page is informational and is neither medical nor legal advice. Nothing sold by MONTKUSH is approved by the FDA to diagnose, treat, cure or prevent any disease; the FDA has not approved CBD as a dietary supplement or as a food ingredient, and marketing claims about sleep, pain, anxiety or recovery are not regulatory findings. Products containing THC are intoxicating and can impair judgement, coordination and reaction time; do not drive or operate machinery after use. THC use can precipitate or worsen anxiety, panic and psychotic symptoms in susceptible people, and should be avoided in pregnancy and breastfeeding and by those with a personal or family history of psychosis. Cannabis hyperemesis syndrome is a recognised cause of cyclical vomiting in regular users and can be mistaken for the gastrointestinal side effects of GLP-1 medicines; anyone experiencing persistent vomiting should tell their clinician about any cannabis use, and persistent vomiting itself requires medical assessment as dehydration from gastrointestinal effects can lead to acute kidney injury. CBD inhibits CYP3A4 and CYP2C19 and can raise blood levels of many other medications; consult a pharmacist or clinician before combining CBD with any prescription medicine. Keep all THC products away from children and pets, for whom even a single edible can require emergency care. Our description of federal law is a general summary for consumer information, is not legal advice, does not address state law, which varies widely and changes frequently, and should not be relied on to determine the legality of any purchase or possession in your jurisdiction; seek qualified legal advice for your own circumstances. Consult a licensed clinician before starting or changing any treatment.
Date reviewed: 8 August 2026. Catalogue and prices were read from the store's public product data on that date, listing 31 products. Variant titles and prices cited: True Vibe Delta-9 THC Gummies - Cherry Limeade at '25 mg CBD + 5 mg THC' in 3-count $9.99, 20-count $39.99, 40-count $69.99 and 60-count $89.99; True Sleep Full Spectrum CBN + CBD Sleep Gummies at '5mg CBN + 25mg CBD + 1mg THC' in 30-count $59.99 and 60-count $109.99; True Sleep Full Spectrum CBN, CBD & THC Softgels at the same cannabinoid loading in 10-count $24.99, 30-count $59.99 and 60-count $109.99; Pure Full Spectrum CBD Softgels at '25mg CBD + 1mg THC' in 10-count $19.99, 30-count $54.99 and 60-count $99.99; True Daily Broad-Spectrum 50 mg CBD Softgels $59.99; True Sleep Advanced Formula Broad-Spectrum CBN & CBD Softgels $64.99, whose listing states 'Broad-spectrum hemp extract THC-Free (Non-Detectable on COA)'. Product listings also state 'All products comply with the 2018 Farm Bill and contain less than 0.3% Delta-9 THC by dry weight' and, on the delta-9 gummies, 'Prop 65 Warning: Product contains THC, recognized by the state of California as a potential reproductive hazard' and '2018 Farm Bill Compliant'. Laboratory data: we downloaded and read the certificate of analysis linked from the delta-9 gummy product page, hosted at coa.montkush.com and titled 'True Vibe Delta-9 THC Gummies 25mg CBD, 5mg THC - Cherry Limeade Lot# 01102024'. It is issued by Landrace Bioscience, 4120 South Creek Road, Chattanooga, TN 37406, sample 01-10-2024-44196, sample received 01/10/2024, report created 01/11/2024, and states on its face 'Expires: 01/10/2025'. The sample is described as 'h2400801 MONTKUSH Hemp CBD D9 Gummy cherry limeade 25mg 5mg 5g', 'Ingestible, Soft Chew', with 'Unit Size: 4.932 g Unit: 1 Gummy'. Reported results include Delta-9-Tetrahydrocannabinol at 5.529 mg per unit, 1.121 mg/g and 0.112%; Cannabidiol at 27.540 mg per unit, 5.584 mg/g and 0.558%; and Not Detected results for Delta-8-THC, THCA-A, Delta-9-THCP, Delta-9-THCV, Delta-9-THCVA, R- and S-Delta-10-THC, 9R- and 9S-HHC, THCO, CBDV, CBDVA, CBDA, CBGA, CBN, CBNA and CBCA, with CBG below the limit of quantitation. The certificate states 'Total THC = THCa * 0.877 + D9-THC' and a Total THC measurement of uncertainty of plus or minus 0.050%. The COA library at coa.montkush.com listed 32 certificates across categories of All Certificates, Gummies (7), Oils (13), Softgel Caps (5), Strength (2) and Topicals (7), including batches dated to 2026 for other products. Two other product pages we checked, for the sleep gummies and the True Daily CBD Oil 2000mg, linked to the COA library homepage rather than to a lot-specific certificate. All per-container THC totals and multiples of the 0.4mg cap in this review are our own arithmetic: for delta-9 products, the measured 5.529mg per gummy multiplied by the container count (3-count approximately 16.6mg, 20-count approximately 110.6mg, 40-count approximately 221.2mg, 60-count approximately 331.7mg, giving approximately 41, 276, 553 and 829 times 0.4mg); for the 1mg-THC products, the labelled 1mg multiplied by container count. These are calculations from the company's own figures, not statements by the company, and actual measured total THC for any given lot may differ. Law: Section 781 of the appropriations law for fiscal 2026 redefines hemp on a total-THC basis inclusive of THCA and delta-8 at not more than 0.3% on a dry weight basis, and caps finished hemp-derived cannabinoid products intended for human consumption at 0.4 milligrams of total THC per container, with container meaning the innermost wrapping, packaging or vessel holding the product for retail sale; the provisions take effect on 12 November 2026, and the U.S. Hemp Roundtable has been reported as estimating that approximately 95% of existing hemp-derived cannabinoid products would be federally unlawful under that standard. The figure of 96 days is calculated from the review date. We express no view on how the cap applies to topical products, which are not consumed, and we have made no attempt to summarise state law. Regulatory searches: a query of the openFDA historical document endpoint for 'MontKush' and 'Mont Kush' returned no matches, and the FDA warning letter search URL we tried returned HTTP 404; we therefore found no FDA warning letter to this company, but our search was limited and absence of a result is not proof that none exists. We did not purchase, receive or test any product. Katalys offer #302 lists a $30.00 flat default commission, with network averages of EPC $0.00, EPS $0.83 and a 0.00% conversion rate.
Affiliate Disclosure: This site may receive compensation from affiliate partners. This programme pays a flat $30.00 per sale regardless of order value — substantially more than the 3 to 6 percent commissions typical of the other merchants we review, and identical whether a reader spends $9.99 or $109.99. Our recommendations here are to buy the smallest THC pack or the THC-free broad-spectrum line, and not to stock up, all of which reduce rather than increase what a reader spends. This does not influence our editorial content or review ratings.